Navigation Links
Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
Date:3/11/2010

TORONTO, March 11 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario, granting Trillium exclusive worldwide rights to commercialize two immunology programs in the areas of hematopoietic stem cell transplantation and cancer.

"We are very excited to have strengthened our immunology franchise and to have reinforced our existing bond with Toronto's world-class immunology community. Our productive long-standing relationship with UHN bodes well for the success of this new collaboration", commented Dr. Niclas Stiernholm, Trillium's CEO. "This transaction exemplifies how ground-breaking Canadian science can and should be commercialized by our domestic biotechnology industry, something that must be encouraged and supported also by government and investor groups."

The first project licensed by TTI is aimed at improving hematopoietic stem cell engraftment by agonizing a key immunoregulatory pathway and thereby preventing the host immune system from attacking transplanted stem cells. The second program is focused on the treatment of several types of cancers by antagonizing the same pathway in cancer stem cells, stimulating the patient's own im
'/>"/>

SOURCE Trillium Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trillium adds industry veteran Dr. Mike Gresser to its Board of Directors
2. Trillium and Biogen Idec enter into global license agreement
3. Trillium Strengthens its Board of Directors
4. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
5. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
6. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
7. Laboratory Products Leader Sterlitech Expands RO Membranes Line
8. Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development
9. Progenitor Cell Therapy Expands Manufacturing Operations
10. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
11. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... LYNBROOK, N.Y. , Aug. 21, 2014 /PRNewswire/ ... a biopharmaceutical company developing first in class collagenase-based ... histolyticum or CCH) in the U.S. and XIAPEX ... statistically significant results from a randomized, double-blind Phase ... of cellulite, or edematous fibrosclerotic panniculopathy. The results ...
(Date:8/21/2014)... Texas (PRWEB) August 21, 2014 ... Seaweed Fertilizer Industry” is a professional and ... market. The report provides basic Seaweed Fertilizer ... and industry chain structure as well as ... market analysis, including domestic market as well ...
(Date:8/21/2014)... August 21, 2014 The College of ... private college in the Mid-Hudson Region to be designated ... begin accepting applications from qualified “high-technology” businesses that align ... very pleased to have been selected for the START-UP ... transformative initiative to stimulate economic development in New York ...
(Date:8/21/2014)... HONG KONG , Aug. 21, 2014  China Cord ... today announced its plan to release financial results for ... August 28, 2014, after market close in the US.  ... call at 8:00 a.m. ET on Friday, August 29, ... brief overview of the Company,s recent developments, followed by ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2
... , , , , Which of the following statements best describes your , ... , , ... , , , ... <a , href="http://www.roche-applied-science.com/pcr/product_find_PCR01a.htm">I , ...
... , for one-step RT-PCR amplification of up to , ... Cat. No. 1 855 476100 reactions , Cat. No. 1 ... Description , , , Components of the Titan ... reaction. The system , includes the following components: , ...
... , , for amplification of GC-rich targets (up to , ... , , , , , , ... Unique enzyme blend of Taq DNA Polymerase and , Pwo DNA Polymerase[a ... The GC-RICH PCR System also includes: , ...
Cached Biology Technology:Find the optimal product for your PCR application 2Titan One Tube RT-PCR System / Kit 2GC-RICH PCR System 2
(Date:8/21/2014)... WHEN: , Saturday to Wednesday, Oct. 18-22, 2014 ... 111 W. Harbor Drive, San Diego, CA 92101 ... sessions and other presentations of the latest research ... Opening plenary session featuring high-scoring abstracts on rare ... of various cancers, and treatment for sun sensitivity ...
(Date:8/21/2014)... standards process, will be available soon and will improve ... in the OnlineFirst version of Nutrition in Clinical ... the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), ... misconnection that can be harmful and even fatal to ... medical devices, components, and accessories to deliver fluids or ...
(Date:8/21/2014)... replicated one of the crucial steps in photosynthesis, opening ... could manufacture hydrogen as a fuel. , "Water is ... prospect to use them to create hydrogen, and do ... the ARC Centre of Excellence for Translational Photosynthesis in ... potential as a zero-carbon replacement for petroleum products, and ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2New feeding tube connectors will improve patient safety 2Water and sunlight the formula for sustainable fuel 2
... secret to longevity may lie in an enzyme with the ... by maintaining the function of the thymus throughout life, according ... than a typical mouse. The study, led by Abbe ... of Pittsburgh School of Medicine, and immunologist at Children,s Hospital ...
... in Montana of the first trace fossil of a dinosaur ... more dinosaur burrows this time on the other side ... published this month in Cretaceous Research , suggests that ... different hemispheres, and spanned millions of years during the Cretaceous ...
... mathematician at the Department of Energy,s Pacific Northwest National ... Award for Scientists and Engineers. The award honors his ... energy needs: cleaning up buried nuclear or toxic contaminants ... Announced by the White House, the PECASE is ...
Cached Biology News:Children's Hospital of Pittsburgh of UPMC scientists identify enzyme important in aging 2Down Under dinosaur burrow discovery provides climate change clues 2Down Under dinosaur burrow discovery provides climate change clues 3PNNL scientist garners early career presidential award 2
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
Denhardt's powder mixture (for 50X stock solution)...
... for monitoring acetylcholinesterase (AChE) activity. This is ... 5 min), non-radioactive and easy to use ... natural substrate, acetylcholine. A series of coupled ... AChE into a change in luminescence. Inhibitors ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
Biology Products: